Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$0.16 - $0.25 $39 - $62
-248 Reduced 1.24%
19,685 $3,000
Q4 2022

Feb 13, 2023

BUY
$0.16 - $0.25 $39 - $62
248 Added 1.26%
19,933 $3,000
Q4 2021

Feb 07, 2022

SELL
$0.31 - $0.58 $17,360 - $32,479
-56,000 Reduced 73.99%
19,685 $6,000
Q1 2021

May 06, 2021

BUY
$0.35 - $2.7 $19,600 - $151,200
56,000 Added 284.48%
75,685 $120,000
Q4 2020

Feb 12, 2021

BUY
$0.07 - $0.25 $1,377 - $4,921
19,685 New
19,685 $5,000

Others Institutions Holding ZOM

About Zomedica Corp.


  • Ticker ZOM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 979,950,016
  • Market Cap $127M
  • Description
  • Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...
More about ZOM
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.